EI
DGX icon

Elkhorn Investments’s Quest Diagnostics DGX Stock Holding History

Elkhorn Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,694
Closed -$1.09M – 104
2017
Q3 		$1.09M Buy
11,694
+926
+9% +$98.3K 0.81% 99
2017
Q2 		$1.15M Sell
10,768
-720
-6% -$76.1K 0.9% 84
2017
Q1 		$1.13M Buy
+11,488
New +$1.1M 0.93% 69

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Elkhorn Investments's DGX Position: Q4 2017 in Review

Elkhorn Investments sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 11,694 shares — an estimated $1.09M sold.

Elkhorn Investments first reported a position in DGX in Q1 2017 and held it in 3 quarters. The position peaked at $1.15M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Elkhorn Investments reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Elkhorn Investments sold 11,694 Quest Diagnostics shares in Q4 2017, an estimated $1.09M.
  • Elkhorn Investments first reported a position in Quest Diagnostics in Q1 2017 and held it in 3 quarters.
  • Elkhorn Investments's Quest Diagnostics position peaked at $1.15M in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Elkhorn Investments's 13F filing for Q4 2017, filed 14 Feb 2018.